Cargando…
Zinc Ionophore (Clioquinol) Inhibition of Human ZIP1-Deficient Prostate Tumor Growth in the Mouse Ectopic Xenograft Model: A Zinc Approach for the Efficacious Treatment of Prostate Cancer
Prostate cancer remains the second leading cause of cancer deaths in males. This is mainly due to the absence of an available efficacious chemotherapy despite decades of research in pursuit of effective treatment approaches. A plausible target for the treatment is the established clinical relationsh...
Autores principales: | Franklin, Renty B., Zou, Jing, Zheng, Yao, Naslund, Michael J., Costello, Leslie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751054/ https://www.ncbi.nlm.nih.gov/pubmed/26878064 |
Ejemplares similares
-
A Proposed Efficacious Treatment with Clioquinol (Zinc Ionophore) and
Cabergoline (Prolactin Dopamine Agonist) for the Treatment of Terminal
Androgen-independent Prostate Cancer. Why and How?
por: Costello, Leslie C., et al.
Publicado: (2019) -
hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands
por: Desouki, Mohamed M, et al.
Publicado: (2007) -
hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer
por: Franklin, Renty B, et al.
Publicado: (2005) -
The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots
por: Costello, Leslie C, et al.
Publicado: (2006) -
The Involvement of Bax in Zinc-Induced Mitochondrial Apoptogenesis in Malignant Prostate Cells
por: Feng, Pei, et al.
Publicado: (2008)